541 related articles for article (PubMed ID: 9368550)
21. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
[TBL] [Abstract][Full Text] [Related]
22. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Ingall TJ; O'Fallon WM; Asplund K; Goldfrank LR; Hertzberg VS; Louis TA; Christianson TJ
Stroke; 2004 Oct; 35(10):2418-24. PubMed ID: 15345796
[TBL] [Abstract][Full Text] [Related]
23. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
IMS Study Investigators
Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018
[TBL] [Abstract][Full Text] [Related]
24. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
[TBL] [Abstract][Full Text] [Related]
25. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.
Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R
Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977
[TBL] [Abstract][Full Text] [Related]
26. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis.
Lou M; Safdar A; Mehdiratta M; Kumar S; Schlaug G; Caplan L; Searls D; Selim M
Neurology; 2008 Oct; 71(18):1417-23. PubMed ID: 18955684
[TBL] [Abstract][Full Text] [Related]
27. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
[TBL] [Abstract][Full Text] [Related]
28. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J
Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877
[TBL] [Abstract][Full Text] [Related]
29. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.
Broderick JP; Palesch YY; Demchuk AM; Yeatts SD; Khatri P; Hill MD; Jauch EC; Jovin TG; Yan B; Silver FL; von Kummer R; Molina CA; Demaerschalk BM; Budzik R; Clark WM; Zaidat OO; Malisch TW; Goyal M; Schonewille WJ; Mazighi M; Engelter ST; Anderson C; Spilker J; Carrozzella J; Ryckborst KJ; Janis LS; Martin RH; Foster LD; Tomsick TA;
N Engl J Med; 2013 Mar; 368(10):893-903. PubMed ID: 23390923
[TBL] [Abstract][Full Text] [Related]
30. Risk of intracerebral hemorrhage after thrombolysis in patients with asymptomatic hemorrhage on T2*.
Aoki J; Shibazaki K; Saji N; Uemura J; Sakamoto Y; Kimura K
Cerebrovasc Dis; 2014; 38(2):107-16. PubMed ID: 25277866
[TBL] [Abstract][Full Text] [Related]
31. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
[TBL] [Abstract][Full Text] [Related]
32. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
Tanne D; Kasner SE; Demchuk AM; Koren-Morag N; Hanson S; Grond M; Levine SR
Circulation; 2002 Apr; 105(14):1679-85. PubMed ID: 11940547
[TBL] [Abstract][Full Text] [Related]
33. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
34. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
[TBL] [Abstract][Full Text] [Related]
35. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
36. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight.
Haley EC; Lewandowski C; Tilley BC
Ann Emerg Med; 1997 Nov; 30(5):676-82. PubMed ID: 9360581
[No Abstract] [Full Text] [Related]
37. Safety of routine IV thrombolysis between 3 and 4.5 h after ischemic stroke.
Uyttenboogaart M; Vroomen PC; Stewart RE; De Keyser J; Luijckx GJ
J Neurol Sci; 2007 Mar; 254(1-2):28-32. PubMed ID: 17257623
[TBL] [Abstract][Full Text] [Related]
38. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
39. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
[TBL] [Abstract][Full Text] [Related]
40. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]